Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma: Current Landscape and Future Direction

Locally and regionally advanced renal cell carcinoma (RCC) can recur at high rates even after visually complete resection of primary disease. Both targeted therapies and immunotherapies represent potential agents that might help reduce recurrence of RCC in these patients. This paper reviews the curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Buller, Dylan M, Antony, Maria, Ristau, Benjamin T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884052/
https://www.ncbi.nlm.nih.gov/pubmed/36718243
http://dx.doi.org/10.2147/OTT.S393296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884052/
https://www.ncbi.nlm.nih.gov/pubmed/36718243
http://dx.doi.org/10.2147/OTT.S393296

Ejemplares similares